The American research company Modern Therapeutics has moved into an operations base in the Karolinska Institutet Science Park, Kisp, in Flemingsberg. This will give the the researchers closer contact with the scientists at Karolinska Institutet and Karolinska University Hospital.
“We will start with test ideas preclinically together with researchers at Karolinska Institutet first. Then we will move on to clinical studies at Karolinska University Hospital with the projects that seem promising,” says Hugh Salter, research director for Swedish operations of Modern Therapeutics in a press release.
Modern Therapeutics plans to use its development platform Messenger RNA Therapeutics to develop new mRNA-based treatments for various diseases. The platform’s Steering Group plans to launch about 10 projects this spring. They will be addressed in a coooperation program spanning several years.
Life Science Sweden